Ovarian cancer experts and patients from Cambridge and Birmingham have developed clear, accessible information in multiple languages about the benefits of genetic testing for ovarian cancer patients.
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say Cambridge scientists.